SEI Investments
KZR

SEI Investments’s Kezar Life Sciences KZR Stock Holding History

SEI Investments’s Portfolio KZR Stock Details KZR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-2,894
Closed -$90.6K – 2724
2023
Q1 		$90.6K Sell
2,894
-570
-16% -$33K ﹤0.01% 2584
2022
Q4 		$244K Sell
3,464
-121
-3% -$8.97K ﹤0.01% 2270
2022
Q3 		$309K Hold
3,585
– – ﹤0.01% 2291
2022
Q2 		$296K Sell
3,585
-598
-14% -$52.7K ﹤0.01% 2329
2022
Q1 		$695K Sell
4,183
-459
-10% -$65.9K ﹤0.01% 1951
2021
Q4 		$776K Buy
+4,642
New +$524K ﹤0.01% 1942

Other funds holding KZR

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

SEI Investments's KZR Position: Q2 2023 in Review

SEI Investments sold out of Kezar Life Sciences (KZR) in Q2 2023, closing a stake of 2,894 shares — an estimated $90.6K sold.

SEI Investments first reported a position in KZR in Q4 2021 and held it in 6 quarters. The position peaked at $776K in Q4 2021. 104 funds tracked by Wall St. Rank hold KZR as of Q2 2023.

  • SEI Investments reported no remaining Kezar Life Sciences position as of Q2 2023 after selling out during the quarter.
  • SEI Investments sold 2,894 Kezar Life Sciences shares in Q2 2023, an estimated $90.6K.
  • SEI Investments first reported a position in Kezar Life Sciences in Q4 2021 and held it in 6 quarters.
  • SEI Investments's Kezar Life Sciences position peaked at $776K in Q4 2021.
  • 104 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q2 2023.

Based on SEI Investments's 13F filing for Q2 2023, filed 11 Aug 2023.